Product image

Getryl Tablets

Getryl Tablets – Effective Glycemic Management

Getryl is an anti-diabetic medication containing Glimepiride, designed to help adult patients manage high blood sugar. It is primarily indicated as an adjunct to diet and exercise to lower blood glucose in patients with non-insulin-dependent (Type 2) diabetes mellitus. Getryl is used when lifestyle modifications alone are insufficient to maintain healthy glycemic levels.

The medication can be used monotherapy or in combination with other drugs. It is frequently used concomitantly with metformin for enhanced control and is also indicated for use alongside insulin in patients with more advanced metabolic needs. As a second-generation sulfonylurea, Getryl works by stimulating the pancreas to release more insulin after meals. It is available in multiple strengths (1mg, 2mg, 3mg, and 4mg) to allow for precise titration of the dose to reach target HbA1c levels. Regular use as part of a comprehensive care plan helps prevent the long-term debilitating complications of chronic diabetes.

  • Indicated for type 2 diabetes mellitus.
  • Stimulates natural insulin release to lower blood sugar.
  • Can be used monotherapy or with metformin and insulin.
  • Available as: Tablets 1MG, 2MG, 3MG, and 4MG.

You may also like

Take it to your cart

Ezole Capsules
Ezole Capsules

Ezole Capsules – Targeted Suppression of Stomach Acid

Ezole Capsules contain Esomeprazole, a potent proton pump inhibitor de...

Risek Capsules
Risek Capsules

Risek Capsules – Comprehensive Acid-Related Disease Management

Risek is a established gastrointestinal treatment used for a...

EN-URA Tablets
EN-URA Tablets

EN-URA Tablets – Targeted Relief for Overactive Bladder

EN-URA is a specialized therapeutic option designed to manage bother...

Saltra Inhaler
Saltra Inhaler

Saltra Inhaler – Comprehensive Respiratory Maintenance Therapy

Saltra Inhaler is a specialized respiratory medication used f...

Image NewsLetter
Icon primary
Newsletter

Subscribe our newsletter

By clicking the button, you are agreeing with our Term & Conditions

Your experience on this site will be improved by allowing cookies Cookie Policy